Pelzel Carl A

Director at Assertio Therapeutics, Inc · on record since Aug 27, 2007
EVP, Chief Operating Officer at Assertio Therapeutics, Inc · on record since Sep 26, 2005

Insider trading activity of Pelzel Carl A

Transactions on record: 13; since Jun 16, 2005

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 14, 2011

Figures computed from official regulatory filings — .

Companies where Pelzel Carl A has traded

Assertio Therapeutics, Inc13 tx · $1.2M · Jan 14, 2011

Track record of Pelzel Carl A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Pelzel Carl A

Co-insiders of Pelzel Carl A

ANIDO VICENTE JRAssertio Therapeutics, Inc
BERNER BRETAssertio Therapeutics, Inc
BIOVAIL LABORATORIES INCAssertio Therapeutics, Inc
Bukofzer StanAssertio Therapeutics, Inc
BURRILL STEVENAssertio Therapeutics, Inc
CALLAGHAN MICHAEL JAssertio Therapeutics, Inc
Cameron TammyAssertio Therapeutics, Inc
DAWES KAREN AAssertio Therapeutics, Inc
DONENBERG PHILIP BAssertio Therapeutics, Inc
FARA JOHN WAssertio Therapeutics, Inc
FOGARTY JAMES PAssertio Therapeutics, Inc
Gosling Matthew MAssertio Therapeutics, Inc
HAMILTON JOHN FAssertio Therapeutics, Inc
HIGGINS ARTHUR JAssertio Therapeutics, Inc
LAVIGNE LOUIS J JRAssertio Therapeutics, Inc
MCKEE WILLIAMAssertio Therapeutics, Inc
Molinelli GavinAssertio Therapeutics, Inc
Moretti August JAssertio Therapeutics, Inc
PROEHL GERALD TAssertio Therapeutics, Inc
Saks Samuel RAssertio Therapeutics, Inc
SAVAGE ROBERT GAssertio Therapeutics, Inc
Schoeneck James AAssertio Therapeutics, Inc
SHELL JOHN NAssertio Therapeutics, Inc
SHELL JOHN WAssertio Therapeutics, Inc
Shively Richard ScottAssertio Therapeutics, Inc
SMITH CRAIG RAssertio Therapeutics, Inc
Srinivas RaoAssertio Therapeutics, Inc
STAPLE PETER DAssertio Therapeutics, Inc
STERN JULIAN NAssertio Therapeutics, Inc

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Assertio Therapeutics, IncSecurity delisted	Jan 14, 2011	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 8, 2010	AwardD (derivative)	200,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 27, 2009	AwardD (derivative)	200,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 9, 2009	Award	30,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 29, 2008	AwardD (derivative)	62,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 29, 2008	AwardD (derivative)	25,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Aug 27, 2007	AwardD (derivative)	400,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Aug 27, 2007	AwardD (derivative)	37,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 1, 2007	AwardD (derivative)	12,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Mar 6, 2007	AwardD (derivative)	50,000	3.31	$165.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 14, 2006	AwardD (derivative)	23,250	6.29	$146.2K	SEC
Assertio Therapeutics, IncSecurity delisted	Sep 26, 2005	AwardD (derivative)	50,000	5.85 USD	$292.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 16, 2005	AwardD (derivative)	150,000	4.25 USD	$637.5K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Assertio Therapeutics, IncSecurity delisted	Jan 14, 2011	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 8, 2010	AwardD (derivative)	200,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 27, 2009	AwardD (derivative)	200,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 9, 2009	Award	30,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 29, 2008	AwardD (derivative)	62,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jan 29, 2008	AwardD (derivative)	25,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Aug 27, 2007	AwardD (derivative)	400,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Aug 27, 2007	AwardD (derivative)	37,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 1, 2007	AwardD (derivative)	12,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Mar 6, 2007	AwardD (derivative)	50,000	3.31	$165.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 14, 2006	AwardD (derivative)	23,250	6.29	$146.2K	SEC
Assertio Therapeutics, IncSecurity delisted	Sep 26, 2005	AwardD (derivative)	50,000	5.85 USD	$292.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Jun 16, 2005	AwardD (derivative)	150,000	4.25 USD	$637.5K	SEC